Related Experiment Videos
Cell-based screening: a high throughput flow cytometry platform for identification of cell-specific targeting
1Vanderbilt University, Box 351620, Station B, Nashville, TN 37235, USA.
Combinatorial Chemistry & High Throughput Screening
|March 23, 2004
Summary
This study introduces a novel flow cytometry method for high-throughput screening of drug targeting molecules. The technique rapidly assesses molecular functionality and stability, enabling faster development of targeted therapies.
Area of Science:
- Biotechnology
- Drug Discovery
- Molecular Biology
Background:
- Targeted drug and gene delivery to specific cell types is crucial for treating various medical conditions.
- Peptide-based targeting molecules face rapid inactivation in vivo, necessitating new approaches.
- Existing screening methods for novel targeting molecules are often limited in throughput or compatibility.
Purpose of the Study:
- To develop a high-throughput, cell-based screening method for evaluating large libraries of targeting molecules.
- To assess the biological functionality and stability of synthesized targeting molecules.
- To overcome limitations of current screening techniques for combinatorial libraries.
Main Methods:
- Utilized flow cytometry for a cell-based screening assay.
- Attached each library molecule to microspheres with unique optical properties ('fingerprints').
- Investigated multiplexing capability and microsphere binding to target cells.
Main Results:
- Developed a method capable of screening at least 75 unique compounds per well, scalable to 1875 compounds per well.
- Demonstrated a 12-fold increase in binding affinity for targeted microspheres compared to controls.
- Confirmed specificity of microsphere binding through competitive inhibition assays.
Conclusions:
- The described flow cytometry method enables rapid and effective screening of large targeting molecule libraries.
- This approach utilizes readily available instrumentation, making it accessible to the research community.
- The methodology supports the development of novel, stable, and effective targeted therapies.